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Genome-wide association studies (GWAS) have successfully identified thousands of single 
nucleotide polymorphisms (SNPs) associated with a large variety of diseases and traits.  The great 
majority of these studies, however, have primarily been performed in populations of European 
ancestry.  Because many SNP allele frequencies differ by ancestral group, it is important to 
understand whether these European-ancestry based SNP-trait associations generalize to other 
ancestry populations.  A recent report inPLoS Biology by Dr. Chris Carlson and colleagues in the 
Public Health Sciences Division provides evidence that while the effect of most SNPs generalize 
from European to non-European populations, a substantial portion have significantly different effects 
in at least one non-European population.  These findings suggest caution when considering the 
application of genetic risk information to other ancestry groups. 
To investigate generalization broadly, the researchers utilized the rich data available in the 
Population Architecture using Genomics and Epidemiology (PAGE) study, a consortium of multi-
ancestry, population-based studies such as the Women’s Health Initiative.  "The exciting thing about 
this research was the opportunity to work in the context of some of the largest available multi-ethnic 
studies in the U.S.," says Dr. Carlson.  These studies have rich phenotypic data on multiple traits in 
multiple populations, allowing the researchers to investigate 68 index SNPs associated with 5 
phenotypes (body mass index, HDL cholesterol, LDL cholesterol, triglycerides, and type 2 diabetes) 
in six ancestry groups (European American, African American, Hispanic American, Asian American, 
Native American, and Pacific Islander).  "Importantly," says Carlson, "this let us try to get away from 
a generalization analysis that is specific to a single trait, and instead focus explicitly on 
generalization."  
Overall, the researchers found that the majority (at least 70%) of European ancestry GWAS findings 
can be expected to show an effect in the same direction for non-European ancestry populations.  At 
the same time, however, the magnitude of the effect varied considerably, with a substantial portion 
of SNPs (25%) showing a significantly different (usually weaker) effect in at least one non-European 
ancestry population.  These inconsistent effects were most frequent in the African American 
population, representing a trend of consistent direction but diluted effect size for these SNPs relative  
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to European ancestry (see figure).  This dilution effect was consistent with the expectations of 
differential tagging, which refers to differences in the correlation between the index SNP and the 
functional variant across different populations.  As was seen, populations with lower correlation 
between the index (tag) SNP and the functional SNP were expected to have diluted effects at the 
index SNP. The researchers further used this differential tagging information in different ancestry 
groups to perform fine-mapping analyses for ten loci, and found that at least half of European 
ancestry GWAS signals tag a common, functional variant.  This suggests that trans-ethnic fine-
mapping may be a powerful approach to identify both population-specific and common signals. 
On a broader scale, these generalization findings have important implications for the translation and 
application of genetic information.  "As the genetic epidemiology community works toward the 
laudable goal of genetic risk prediction models that could be clinically actionable," says Carlson, 
"these findings caution that the models need to be recalibrated for application in populations with 
different genetic ancestries."  Such recalibrations will require genetic studies that include non-
European ancestries, in order to ensure the equitable translation of genetic information into public 
health and clinical applications across populations.  Furthermore, by including multiple ancestral 
groups in genetic studies, trans-ethnic analyses can help identify the functional genetic variation that 
is shared in common across ancestries.  Says Carlson, "as the functional variants are identified at 
each locus, risk prediction models based directly on genotype at the functional variants may 
extrapolate robustly across populations."  While the identification of functional variants remains 
challenging, the results from this paper suggest that the effort will be both necessary and rewarding. 
Other PHS investigators contributing to this project were Drs. Ulrike Peters, Cara Carty, and Charles 
Kooperberg, with additional support from Alicia Young and members of the WHI/FHCRC component 
of the PAGE study. 
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Image adapted from Carlson et al. PLoS Biol 2013. 
Generalization analysis in the African American population, 
plotting the ratio of the effect size in African Americans to the 
effect size in European Americans (y axis) against the p-value 
for the trait association in European Americans (x axis). These 
ratios are generally between 0 and 1, suggesting two trends: the 
general consistency in direction of effect in both populations, and 
the general dilution of effect size in the African Americans. 
 
